Bizarre Medical History copertina

Bizarre Medical History

Bizarre Medical History

Di: Creator at Obomedia
Ascolta gratuitamente

Ever wondered about the strange cures, bizarre medical practices, and shocking experiments from history? Bizarre Medical History uncovers the most unbelievable and often disturbing chapters in the annals of medicine.

Join us for a fascinating exploration into the forgotten corners of medical history, from ancient remedies to the origins of modern surgery, revealing the incredible journeys and sometimes misguided attempts to heal. We delve into the lives of pioneering doctors, the patients who endured their treatments, and the fascinating evolution of healthcare. Discover the surprising origins of common medical terms and the groundbreaking (and sometimes terrifying) discoveries that shaped our understanding of the human body.

New episodes arrive every single day, Monday through Sunday, bright and early at 4:00 AM, offering a daily dose of medical oddities and historical insights. Each episode provides a meticulously researched narrative, perfect for your morning commute or daily routine.

This podcast is for anyone curious about the human body, the history of science, or simply enjoys a well-told story about humanity's quest for health. If you're intrigued by historical medicine, medical curiosities, and the strange path to modern healthcare, this is your ultimate destination.

Subscribe now to Bizarre Medical History and unlock the secrets of the past.© 2026 OBOMEDIA Creators
Crimini reali
  • invisible pharmacology at a public event
    Aug 22 2026
    invisible pharmacology at a public event

    Calmness can be manufactured: a cardiac drug patented in 1962 and approved in 1964 was later found to concentrate in the brain up to 33 times more than in blood, altering memory, fear and performance in ways no regulator had anticipated. How did a medicine meant for failing hearts become an invisible influence on minds and public life?

    In this episode, we trace the history, chemistry and unexpected journeys of propranolol from its invention to widespread use, and ask where medicine ends and other forms of control begin.

    Person: James W. Black
    Date: 1962 (patent), 1964 (approval)
    Location: Alderley Park, Cheshire
    Topic: Propranolol pharmacokinetics and uses
    Event: 1964 Tokyo pistol shooting (arm stillness observed)

    - Propranolol was patented in 1962 and approved for human use in 1964.
    - The drug was marketed under the trade name Inderal one year after approval.
    - Only about 25% of an oral dose survives first-pass metabolism to circulate systemically.
    - Propranolol accumulates in the brain at 15 to 33 times the concentration found in blood.
    - In a single year it reached number 69 on the US prescription list and was dispensed over nine million times.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    Mostra di più Mostra meno
    28 min
  • A blood pressure pill stripped an Olympic athlete of two medals in Beijing 2008
    Aug 21 2026
    A blood pressure pill stripped an Olympic athlete of two medals in Beijing 2008

    Fear and fascination collide: a common blood pressure drug, propranolol, taken by millions, silenced the physical tremors of performers and quietly altered how traumatic memories are stored - and it cost an Olympic shooter his medals in Beijing. How did a heart medicine become a disqualifying performance aid and a tool to soften trauma?

    In this episode, we trace the journey of propranolol from James Whyte Whyte’s lab to the Olympic podium and to studies of memory reconsolidation. We explain what the drug does in the body and brain, why it steadied hands for musicians, and how that same effect led to Kim Jong-su losing two Olympic medals - and we ask what this means for medicine, sport, and memory.

    Person: Kim Jong-su
    Event: 2008 Olympic Games
    Medals: Silver (10m air pistol), Bronze (50m pistol) - subsequently stripped
    Drug: Propranolol
    Scientist: James Whyte Whyte

    - Propranolol reached the market in the early 1960s under the brand name Inderal.
    - By 1977, 27% of surveyed UK performers had used beta blockers before performances.
    - Propranolol’s brain-to-blood ratio can be as high as 15:1 to 33:1, far higher than atenolol’s ~0.2:1.
    - James Whyte Whyte received the Nobel Prize in Physiology or Medicine in 1988 in part for developing propranolol.
    - Memory reconsolidation is a roughly six-hour window after an experience during which norepinephrine is required to stabilize memories.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    Mostra di più Mostra meno
    27 min
  • The Heart Drug That Quieted Fear - And Shocked the World
    Aug 20 2026
    The Heart Drug That Quieted Fear - And Shocked the World

    Fear feels conquerable when the body stops betraying you: a heart-slowing tablet from 1964 eventually reached 9 million dispensings in the U.S. and the WHO Essential Medicines List - yet its most startling effect was discovered in the brain. How did a drug meant for failing hearts come to erase the physical signature of fear, and what did that mean for athletes, performers, and medicine?

    In this episode, we trace the drug's path from Alderley Park labs to global use, describe its mechanism in heart and brain, and unpack the clinical and ethical questions that emerged as propranolol spread into new indications and public life. What happens when a cardiovascular medicine also quiets the body's alarm system?

    Person: James W. Black
    Date: 1962 (patent filed), 1964 (approval), 1965 (market)
    Location: Alderley Park, Cheshire, England
    Topic: Propranolol mechanism and clinical history
    Event: 1987 study by the International Conference of Symphony and Opera Musicians

    - Propranolol was patented in 1962, approved for medical use in 1964, and marketed as Inderal in 1965.
    - By 2023, propranolol had been dispensed more than 9,000,000 times in the United States.
    - Propranolol reaches the brain at 15 to 33 times its blood concentration, versus atenolol at roughly 0.2 times.
    - The molecule blocks beta-1 receptors in the heart and beta-2 receptors in the airways, interrupting the adenylate cyclase → cAMP → protein kinase A → calcium influx cascade.
    - A 1987 study by the International Conference of Symphony and Opera Musicians reported a relevant finding involving performance and propranolol with a 27% figure mentioned.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    Mostra di più Mostra meno
    25 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione